
Menu
Agenda
Wednesday, October 18
Thursday, October 19
Friday, October 20
Saturday, October 21
Wednesday, October 18
Wednesday, October 18 | ||
---|---|---|
Pre-Conference:
The Role of Digital Health & Technology in Cardiometabolic Risk Reduction: Where We Are and Where Are We Going | ||
12:00 PM — 12:05 PM | Opening Remarks Chair: Seth Martin, MD, MHS | |
12:05 PM — 12:25 PM | Setting the Stage: What Digital Health Means for Clinicians and Patients | |
Technology & Digital Health in Lifestyle and Obesity | ||
12:25 PM – 12:45 PM | Health and Care Apps for Lifestyle and Obesity: The Importance of Self-Monitoring | |
12:45 PM – 1:05 PM | Continuous Glucose Monitoring: The New Frontier in Lifestyle Management? Athena Philis-Tsimikas, MD | |
1:05 PM – 1:25 PM | Changing Behavior Using Digital Health for Long Term Weight Management Martin S. Hagger, PhD | |
Technology & Digital Health in Type 2 Diabetes | ||
1:25 PM – 1:45 PM | The Role of CGM in the Management of Type 2 Diabetes: Patient Selection & Important Pearls Grazia Aleppo, MD, FACE, FACP | |
1:45 PM – 2:05 PM | Insulin Delivery and Insulin Pumps in Patients with Type 2 Diabetes Viral S. Shah, MD | |
2:05 PM – 2:25 PM | Glucose-responsive Insulin Delivery and Closed Loop Systems: The Current State & What the Future Holds | |
2:25 PM – 2:55 PM | Refresh and Recharge Break | |
2:55 PM – 3:55 PM | Primetime CME Symposium | |
Technology & Digital Health in CVD & CVD Risk Reduction | ||
3:55 PM – 4:15 PM | Technology to Close Gaps in Hypertension Care Daichi Shimbo, MD | |
4:15 PM – 4:35 PM | Advances in Digital Health for Arrhythmia Management | |
4:35 PM – 4:55 PM | Health Technologies for CVD Prevention | |
Technology & Digital Health in Cardiometabolic Health: Discussions & Practical Strategies for Implementation | ||
4:55 PM – 5:15 PM | Discussions & Perspectives: What Role Does Technology and Digital Health Play in Addressing Disparities in Care? Moderator: Seth Martin, MD, MHS Panelists: Yvonne Commodore-Mensah, PhD, MHS, RN | |
5:15 PM – 5:45 PM | How Do Clinicians and Patients Better Use This Data: Challenges and Possible Solutions Moderator: Seth Martin, MD, MHS Panelists: Eric D. Peterson, MD, MPH | |
5:45 PM – 6:15 PM | Refresh and Recharge Break | |
6:15 PM – 6:45 PM | Fireside Chat: How Industry and Academic Medicine Can Work Together (Non-CME) | |
6:45 PM – 7:15 PM | Fireside Chat: What Would the World of Cardiometabolic Care Look Like If We Have Successful Academic and Industry Collaborations? (Non-CME) |
Thursday, October 19
Thursday, October 19 | ||
---|---|---|
FDA Updates and Keynote | ||
7:00 AM – 7:45 AM | PME Breakfast Symposium (non-CME) Sponsored by AstraZeneca. | |
7:45 AM – 8:15 AM | Refresh and Recharge Break | |
8:15 AM – 10:15 AM | Opening Remarks & FDA Update and Late Breaking Trials Moderator: Christie M. Ballantyne, MD Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand; Anne L. Peters, MD | |
10:15 AM – 10:45 AM | Keynote Address Screening for Social Determinants of Cardiometabolic Health & Practice Implications | |
10:45 AM – 11:15 AM | Exhibit Hall Break | |
11:15 AM – 12:15 PM | PME Lunch Symposium (non-CME) Sponsored by Novo Nordisk | |
Session I: Obesity & Lifestyle | ||
12:15 PM – 12:45 PM | Exhibit Hall Break | |
12:45 PM – 12:45 PM | Opening Remarks Robert H. Eckel, MD | |
12:45 PM– 1:45 PM | Diving Deeper Into Exercise Regimens for Cardiometabolic Health | |
1:45 PM– 2:45 PM | Debate and Discussion: Is it Time to Compare High-Intensity Pharmacotherapy to Surgery for the Management of Obesity? Donna H. Ryan, MD; Christopher D. Still, DO | |
2:45 PM – 3:15 PM | Exhibit Hall Break | |
3:15 PM – 3:35 PM | The Intersection of Sleep and Cardiometabolic Risk: Important Connections and Practice Implications Sirimon Reutrakul, MD | |
3:35 PM – 4:35 PM | Primetime CME Symposium | |
4:35 PM – 5:30 PM | Challenging Obesity Cases & Panel Discussion Moderator: Robert H. Eckel, MD Panelists: Donna H. Ryan, MD; Sirimon Reutrakul, MD; Christopher D. Still, DO | |
5:30 PM – 6:30 PM | Welcome Reception | |
6:30 PM – 7:30 PM | Dinner Symposium |
Friday, October 20
Friday, October 20 | 7:00 AM – 8:00 AM | Breakfast Symposium |
---|---|---|
Session II: Dyslipidemia/Atherosclerosis/Thrombosis | ||
8:00 AM – 8:05 AM | Opening Remarks Christie M. Ballantyne, MD | |
8:05 AM – 8:25 AM | Lp(a): The Assessment of Risk in the Absence of Clinical Trial Data Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC | |
8:25 AM – 8:45 AM | Statin Intolerance: How To Assess and Practical Pearls for Addressing It Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC | |
8:45 AM – 9:05 AM | Hypertriglyceridemia: Trials, Tribulations, and Transition to Clinical Practice Michael D. Shapiro, DO | |
9:05 AM – 10:05 AM | Primetime CME Symposium | |
10:05 AM – 10:25 AM | Non-Statin Therapies for LDL-C Lowering: Making Sense of Recent Data and Recommendations Pamela B. Morris, MD | |
10:25 AM – 11:25 AM | Challenging Lipid Management Cases & Panel Discussion Moderator: Christie M. Ballantyne, MD Panelists: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC; Pamela B. Morris, MD; Michael D. Shapiro, DO | |
11:25 AM – 11:55 AM | Exhibit Hall Break | |
11:55 AM – 12:55 PM | PME Lunch Symposium (non-CME) Sponsored by Ionis Pharmaceuticals, Inc. | |
12:55 PM – 1:25 PM | Exhibit Hall Break | |
Session III: Diabetes | ||
1:25 PM – 1:25 PM | Opening Remarks Anne L. Peters, MD | |
1:25 PM – 1:45 PM | Have We Forgotten About Glycemic Management in Type 2 Diabetes? Or Where Are We With Respect to Glycemic Control in T2D – A 2023 update | |
1:45 PM – 2:10 PM | Early Treatment Intensification in Type 2 Diabetes Juan P. Frias, MD | |
2:10 PM – 3:10 PM | Primetime CME Symposium | |
3:10 PM – 3:40 PM | Exhibit Hall Break | |
3:40 PM – 4:00 PM | Optimizing Glycemic Control With Commonly-Available Combination Therapies: Tips and Pearls Athena Philis-Tsimikas, MD | |
4:00 PM – 4:20 PM | How Social Determinants of Health Impact Type 2 Diabetes Treatment | |
4:20 PM – 5:20 PM | Challenging Diabetes Management Cases & Panel Discussion Moderator: Anne L. Peters, MD Panelists: Juan P. Frias, MD; Athena Philis-Tsimikas, MD | |
5:20 PM – 6:20 PM | Happy Hour & Giveaways | |
6:20 PM – 7:20 PM | Dinner Symposium |
Saturday, October 21
Saturday, October 21 | ||
---|---|---|
Session IV: CardioRenal | ||
7:00 AM – 8:00 AM | PME Breakfast Symposium (non-CME) Sponsored by VeroScience. | |
8:00 AM – 8:00 AM | Opening Remarks Keith C. Ferdinand, MD | |
8:00 AM – 8:35 AM | Be Careful What You Believe: Lessons From Clinical Trial Data Keith C. Ferdinand, MD | |
8:35 AM – 9:05 AM | Resistant Hypertension: Definitions, Current Treatment and Emerging Approaches Debbie Cohen, MD | |
9:05 AM – 9:35 AM | Sleep and Hypertension: A Two-Way Street Virend K. Somers, MD, PhD | |
9:35 AM – 9:50 AM | Refresh and Recharge Break | |
9:50 AM – 10:50 AM | Primetime Symposium | |
10:50 AM – 11:20 AM | The Role of Steroidal and Non-steroidal MRAs in Cardiorenal Risk Reduction Ajay K. Singh, MBBS, FRCP, MBA | |
11:20 AM – 11:40 AM | Which Patients Should Get SGLT2is and GLP-1 RAs for cardiorenal risk reduction? Interpreting Guidelines and Clinical Trials to Patient Care | |
11:40 AM – 12:00 PM | The Continuum of Heart Failure | |
12:00 PM – 1:00 PM | Challenging Cardiorenal Cases & Expert Panel Discussion Moderator: Keith C. Ferdinand, MD Panelists: Debbie Cohen, MD; Ajay K. Singh, MBBS, FRCP, MBA; Virend K. Somers, MD, PhD |